LBA-03 Efficacy and Safety of Regorafenib Versus Placebo in Patients with Hepatocellular Carcinoma (HCC) Progressing on Sorafenib: Results of the International, Randomized Phase 3 RESORCE Trial
ANNALS OF ONCOLOGY(2016)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined